ULTRAGENYX PHARMACEUTICAL INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
ULTRAGENYX PHARMACEUTICAL INC. (RARE) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 69.93 million shares for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-07-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-07-29
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-06-30 was 69.93M shares, a 3.43% increase year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2022-03-31 was 69.52M shares, a 3.60% increase year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 68.58M shares, a 6.02% increase year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 67.88M shares, a 11.84% increase year-over-year.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 67.80M shares, a 11.42% increase from fiscal 2020.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 60.85M shares, a 7.54% increase from fiscal 2019.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 56.58M shares, a 13.66% increase from fiscal 2018.
- ULTRAGENYX PHARMACEUTICAL INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 49.78M shares, a 17.25% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|
| 2022-06-30 | 69.93M shares 10-Q · filed 2022-07-29 | 69.72M shares 10-Q · filed 2022-07-29 | 69.34M shares derived: average of 3 quarters · filed 2022-07-29 | 68.97M shares derived: average of 4 quarters · filed 2022-07-29 | |
| 2022-03-31 | 69.52M shares 10-Q · filed 2022-05-06 | 69.05M shares derived: average of 2 quarters · filed 2022-05-06 | 68.66M shares derived: average of 3 quarters · filed 2022-05-06 | 68.40M shares derived: average of 4 quarters · filed 2022-07-29 | |
| 2021-12-31 | 68.58M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 68.23M shares derived: average of 2 quarters · filed 2022-02-15 | 68.02M shares derived: average of 3 quarters · filed 2022-07-29 | 67.80M shares 10-K · filed 2022-02-15 | |
| 2021-09-30 | 67.88M shares 10-Q · filed 2021-11-03 | 67.74M shares derived: average of 2 quarters · filed 2022-07-29 | 67.53M shares 10-Q · filed 2021-11-03 | 66.82M shares derived: average of 4 quarters · filed 2022-07-29 | |
| 2021-06-30 | 67.61M shares 10-Q · filed 2022-07-29 | 67.36M shares 10-Q · filed 2022-07-29 | 66.47M shares derived: average of 3 quarters · filed 2022-07-29 | 65.02M shares derived: average of 4 quarters · filed 2022-07-29 | |
| 2021-03-31 | 67.10M shares 10-Q · filed 2022-05-06 | 65.90M shares derived: average of 2 quarters · filed 2022-05-06 | 64.16M shares derived: average of 3 quarters · filed 2022-05-06 | ||
| 2020-12-31 | 64.69M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 62.69M shares derived: average of 2 quarters · filed 2022-02-15 | 60.85M shares 10-K · filed 2022-02-15 | ||
| 2020-09-30 | 60.69M shares 10-Q · filed 2021-11-03 | 59.56M shares 10-Q · filed 2021-11-03 | |||
| 2020-03-31 | 58.00M shares 10-Q · filed 2021-05-05 | 57.91M shares derived: average of 2 quarters · filed 2022-02-15 | 57.84M shares derived: average of 3 quarters · filed 2022-02-15 | 57.76M shares derived: average of 4 quarters · filed 2022-02-15 | |
| 2019-12-31 | 57.82M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 57.76M shares derived: average of 2 quarters · filed 2022-02-15 | 57.68M shares derived: average of 3 quarters · filed 2022-02-15 | 56.58M shares 10-K · filed 2022-02-15 | |
| 2019-09-30 | 57.71M shares 10-Q · filed 2020-10-27 | 57.61M shares derived: average of 2 quarters · filed 2020-10-27 | 56.16M shares 10-Q · filed 2020-10-27 | 54.80M shares derived: average of 4 quarters · filed 2021-02-12 | |
| 2019-06-30 | 57.52M shares 10-Q · filed 2019-08-02 | 55.38M shares 10-Q · filed 2019-08-02 | 53.83M shares derived: average of 3 quarters · filed 2021-02-12 | 52.95M shares derived: average of 4 quarters · filed 2021-02-12 | |
| 2019-03-31 | 53.21M shares 10-Q · filed 2020-05-07 | 51.98M shares derived: average of 2 quarters · filed 2021-02-12 | 51.43M shares derived: average of 3 quarters · filed 2021-02-12 | 51.03M shares derived: average of 4 quarters · filed 2021-02-12 | |
| 2018-12-31 | 50.76M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | 50.54M shares derived: average of 2 quarters · filed 2021-02-12 | 50.30M shares derived: average of 3 quarters · filed 2021-02-12 | 49.78M shares 10-K · filed 2021-02-12 | |
| 2018-09-30 | 50.32M shares 10-Q · filed 2019-11-06 | 50.07M shares derived: average of 2 quarters · filed 2019-11-06 | 49.45M shares 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | 49.82M shares 10-Q · filed 2019-08-02 | 49.05M shares 10-Q · filed 2019-08-02 | |||
| 2017-12-31 | 43.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | 42.81M shares derived: average of 2 quarters · filed 2020-02-14 | 42.65M shares derived: average of 3 quarters · filed 2020-02-14 | 42.45M shares 10-K · filed 2020-02-14 | |
| 2017-09-30 | 42.47M shares 10-Q · filed 2018-11-06 | 42.41M shares derived: average of 2 quarters · filed 2018-11-06 | 42.22M shares 10-Q · filed 2018-11-06 | 41.86M shares derived: average of 4 quarters · filed 2019-02-20 | |
| 2017-06-30 | 42.35M shares 10-Q · filed 2018-08-03 | 42.10M shares 10-Q · filed 2018-08-03 | 41.66M shares derived: average of 3 quarters · filed 2019-02-20 | 41.13M shares derived: average of 4 quarters · filed 2019-02-20 | |
| 2017-03-31 | 41.84M shares 10-Q · filed 2017-05-05 | 41.32M shares derived: average of 2 quarters · filed 2019-02-20 | 40.73M shares derived: average of 3 quarters · filed 2019-02-20 | 40.30M shares derived: average of 4 quarters · filed 2019-02-20 | |
| 2016-12-31 | 40.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | 40.17M shares derived: average of 2 quarters · filed 2019-02-20 | 39.79M shares derived: average of 3 quarters · filed 2019-02-20 | 39.59M shares 10-K · filed 2019-02-20 | |
| 2016-09-30 | 39.55M shares 10-Q · filed 2017-11-03 | 39.29M shares derived: average of 2 quarters · filed 2017-11-03 | 39.18M shares 10-Q · filed 2017-11-03 | 39.11M shares derived: average of 4 quarters · filed 2018-02-21 | |
| 2016-06-30 | 39.03M shares 10-Q · filed 2017-07-28 | 39.00M shares 10-Q · filed 2017-07-28 | 38.96M shares derived: average of 3 quarters · filed 2018-02-21 | 38.78M shares derived: average of 4 quarters · filed 2018-02-21 | |
| 2016-03-31 | 38.97M shares 10-Q · filed 2017-05-05 | 38.92M shares derived: average of 2 quarters · filed 2018-02-21 | 38.70M shares derived: average of 3 quarters · filed 2018-02-21 | 38.01M shares derived: average of 4 quarters · filed 2018-02-21 | |
| 2015-12-31 | 38.87M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | 38.57M shares derived: average of 2 quarters · filed 2018-02-21 | 37.69M shares derived: average of 3 quarters · filed 2018-02-21 | 36.78M shares 10-K · filed 2018-02-21 | |
| 2015-09-30 | 38.27M shares 10-Q · filed 2016-11-08 | 37.10M shares derived: average of 2 quarters · filed 2016-11-08 | 36.09M shares 10-Q · filed 2016-11-08 | 35.04M shares derived: average of 4 quarters · filed 2017-02-17 | |
| 2015-06-30 | 35.94M shares 10-Q · filed 2016-08-09 | 35.00M shares 10-Q · filed 2016-08-09 | 34.98M shares 10-Q · filed 2015-08-14 | 33.96M shares derived: average of 3 quarters · filed 2017-02-17 | 33.38M shares derived: average of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | 34.01M shares 10-Q · filed 2016-05-10 | 32.97M shares derived: average of 2 quarters · filed 2017-02-17 | 32.52M shares derived: average of 3 quarters · filed 2017-02-17 | 31.91M shares derived: average of 4 quarters · filed 2017-02-17 | |
| 2014-12-31 | 31.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | 31.78M shares derived: average of 2 quarters · filed 2017-02-17 | 31.21M shares derived: average of 3 quarters · filed 2017-02-17 | 28.76M shares 10-K · filed 2017-02-17 | |
| 2014-09-30 | 31.63M shares 10-Q · filed 2015-11-10 | 30.84M shares derived: average of 2 quarters · filed 2015-11-10 | 27.70M shares 10-Q · filed 2015-11-10 | 21.75M shares derived: average of 4 quarters · filed 2016-02-26 | |
| 2014-06-30 | 30.06M shares 10-Q · filed 2015-08-14 | 25.70M shares 10-Q · filed 2015-08-14 | 18.46M shares derived: average of 3 quarters · filed 2016-02-26 | 14.75M shares derived: average of 4 quarters · filed 2016-02-26 | |
| 2014-03-31 | 21.58M shares 10-Q · filed 2015-05-12 | 12.67M shares derived: average of 2 quarters · filed 2016-02-26 | 9.65M shares derived: average of 3 quarters · filed 2016-02-26 | 8.05M shares derived: average of 4 quarters · filed 2016-02-26 | |
| 2013-12-31 | 3.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | 3.69M shares derived: average of 2 quarters · filed 2016-02-26 | 3.54M shares derived: average of 3 quarters · filed 2016-02-26 | 3.38M shares 10-K · filed 2016-02-26 | |
| 2013-09-30 | 3.62M shares 10-Q · filed 2014-11-10 | 3.44M shares derived: average of 2 quarters · filed 2014-11-10 | 3.26M shares 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | 3.26M shares 10-Q · filed 2014-08-11 | 3.08M shares 10-Q · filed 2014-08-11 | |||
| 2013-03-31 | 2.89M shares 10-Q · filed 2014-05-12 | ||||
| 2012-12-31 | 1.38M shares 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |